HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab

Characterization of the molecular mechanisms underlying antitumor immune responses and immune escape mechanisms has resulted in the development of more effective immunotherapeutic strategies, including immune checkpoint inhibitor (ICI) therapy. ICIs can induce durable responses in patients with adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladányi, Andrea, Hegyi, Barbara, Balatoni, Tímea, Liszkay, Gabriella, Rohregger, Raphael, Waldnig, Christoph, Dudás, József, Ferrone, Soldano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073691/
https://www.ncbi.nlm.nih.gov/pubmed/35531074
http://dx.doi.org/10.3389/pore.2022.1610297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073691/
https://www.ncbi.nlm.nih.gov/pubmed/35531074
http://dx.doi.org/10.3389/pore.2022.1610297

Ejemplares similares